controversy about Zohydro ER (zoh-HYE-droh), the first single-ingredient, extended-release form of hydrocodone

April 2014

See updated DEA information concerning the rescheduling of hydrocodone combination products to Schedule II.

You'll hear lots of controversy about Zohydro ER (zoh-HYE-droh), the first single-ingredient, extended-release form of hydrocodone.

Think of it as an alternative to other LONG-acting opioids...OxyContin, MS Contin, Avinza, etc.

Zohydro ER contains 10 to 50 mg/cap of hydrocodone...to be given every 12 hours for severe CHRONIC pain.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Pharmacy Technicians big changes in the roles of pharmacy technicians
Diabetes more emphasis on improving care of diabetes patients while also improving performance on quality measures
Respiratory & Allergy new once-daily combo inhaler for COPD, Anoro Ellipta (a-NOR-oh ee-LIP-ta, umeclidinium/vilanterol)
Women's Health whether acetaminophen is risky during pregnancy
Neurology & Pain controversy about Zohydro ER (zoh-HYE-droh), the first single-ingredient, extended-release form of hydrocodone
Neurology & Pain how to handle controlled substance Rxs for patients with a "pain contract" or treatment agreement
Pediatrics dexamethasone for asthma exacerbations
Men's Health how Stendra (STEN-druh, avanafil) compares to other drugs for erectile dysfunction
Heart Failure New digoxin strengths will raise questions about appropriate use
Stroke more focus on preventing strokes in YOUNGER WOMEN
Hypertension how to manage SEVERE hypertension
Ulcers Are H2-blockers making a big comeback for stress ulcer prophylaxis
Phosphate Velphoro (vel-FOUR-oh, sucroferric oxyhydroxide), a new phosphate binder for patients with chronic kidney disease
Restless Legs more interest in using pregabalin (Lyrica) for restless legs syndrome